Endo And Premier, Inc. Collaborate To Address Pitocin (Oxytocin Injection, USP) Shortage
Portfolio Pulse from Benzinga Newsdesk
Endo International plc (OTC:ENDPQ) and Premier, Inc. (NASDAQ:PINC) have announced a collaboration to address the shortage of Pitocin, a critical labor and delivery drug. Endo's Par Sterile Products business will supply Pitocin vials through Premier's ProvideGx and PremierProRx programs. The partnership aims to provide a stable product supply and enhance pricing predictability.
July 17, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Endo International's collaboration with Premier, Inc. to address the Pitocin shortage could enhance its reputation as a reliable supplier and potentially increase its revenues.
The collaboration with Premier, Inc. to address the Pitocin shortage positions Endo International as a reliable supplier. This could potentially lead to increased demand for its products and subsequently, increased revenues.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Premier, Inc.'s collaboration with Endo International to address the Pitocin shortage could enhance its service offerings and potentially increase its revenues.
The collaboration with Endo International to address the Pitocin shortage allows Premier, Inc. to enhance its service offerings. This could potentially lead to increased demand for its services and subsequently, increased revenues.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100